Loading institutional data...
Loading institutional data...
Held by 234 of 5,944 reporting institutions (93th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
6/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $5.1B FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 8 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -3%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 8 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $76.72B 100.0% | $40.87B 100.0% | $30.68B 100.0% | $26.86B 100.0% | $20.99B 100.0% | $5.84B 100.0% | $2.32B 100.0% | $9.7M 100.0% |
| Cost of Revenue | $62.25B 81.1% | $35.02B 85.7% | $30.22B 98.5% | $23.77B 88.5% | $18.37B 87.5% | $5.58B 95.4% | $2.88B 124.0% | $12.1M 124.3% |
| Gross Profit | $14.47B 18.9% | $5.85B 14.3% | $451.2M 1.5% | $3.09B 11.5% | $2.62B 12.5% | $266.0M 4.6% | -$558.1M -24.0% | -$2.4M -24.3% |
| Research & Development | $9.49B 12.4% | $6.46B 15.8% | $5.28B 17.2% | $5.21B 19.4% | $4.11B 19.6% | $1.73B 29.5% | $2.07B 89.2% | $1.05B 10830.6% |
| Selling, General & Admin | $9.40B 12.3% | $6.87B 16.8% | $6.56B 21.4% | $6.69B 24.9% | $5.31B 25.3% | $2.92B 50.0% | $1.16B 50.2% | $642.5M 6620.0% |
| Total Operating Expenses | $17.24B 22.5% | $12.50B 30.6% | $11.34B 37.0% | $11.90B 44.3% | $9.42B 44.9% | $4.65B 79.5% | $3.23B 139.4% | $1.69B 17450.6% |
| Operating Income | -$2.77B -3.6% | -$6.66B -16.3% | -$10.89B -35.5% | -$8.71B -32.4% | -$6.58B -31.3% | -$4.29B -73.5% | -$3.78B -162.9% | -$1.69B -17459.7% |
| Interest Expense | $379.9M 0.5% | $344.0M 0.8% | $268.7M 0.9% | $132.2M 0.5% | $55.3M 0.3% | $22.5M 0.4% | $32.0M 1.4% | $5.8M 60.0% |
| Interest & Investment Income | $1.16B 1.5% | $1.37B 3.4% | $1.26B 4.1% | $1.06B 3.9% | $743.0M 3.5% | $133.0M 2.3% | $88.8M 3.8% | $65.4M 673.6% |
| Other Income (Expense), net | $44.8M 0.1% | $108.2M 0.3% | $41.9M 0.1% | $36.3M 0.1% | $70.3M 0.3% | $9.2M 0.2% | $4.4M 0.2% | -$18.1M -186.5% |
| Pretax Income | -$1.16B -1.5% | -$5.83B -14.3% | -$10.39B -33.9% | -$9.12B -34.0% | -$4.84B -23.0% | -$2.73B -46.7% | -$3.69B -159.0% | -$1.40B -14411.9% |
| Income Tax Expense | $13.6M 0.0% | -$69.8M -0.2% | $36.8M 0.1% | $24.7M 0.1% | $26.0M 0.1% | $1.2M 0.0% | $1K 0.0% | $0 0.0% |
| Net Income | -$1.14B -1.5% | -$5.79B -14.2% | -$10.38B -33.8% | -$9.14B -34.0% | -$4.86B -23.2% | -$2.73B -46.7% | -$3.69B -159.0% | -$1.40B -14411.9% |
| Per Share | ||||||||
| EPS (Basic) | $-0.60 | $-3.06 | $-5.96 | $5.34 | $-2.96 | $-6.48 | — | — |
| EPS (Diluted) | $-0.60 | $-3.06 | $-5.96 | $5.34 | $-2.96 | $-6.48 | — | — |
| Weighted Avg Shares (Basic) | 1.90B | 1.89B | 1.74B | 1.71B | 1.64B | 754.3M | — | — |
| Weighted Avg Shares (Diluted) | 1.90B | 1.89B | 1.74B | 1.71B | 1.64B | 754.3M | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
No trend data available for this metric.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~3.5% on $10.9B of debt.
Cash of $17.3B fully covers short-term debt of $6.1B.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
No current price collected.
Nothing notable to watch.
Where each multiple sits in its own 6-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 6-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 124.3 | 124.0 | 95.4 | 87.5 | 88.5 | 98.5 | 85.7 | 81.1 |
| Gross Profit | -24.3 | -24.0 | 4.6 | 12.5 | 11.5 | 1.5 | 14.3 | 18.9 |
| R&D | 10830.6 | 89.2 | 29.5 | 19.6 | 19.4 | 17.2 | 15.8 | 12.4 |
| SG&A | 6620.0 | 50.2 | 50.0 | 25.3 | 24.9 | 21.4 | 16.8 | 12.3 |
| Operating Income | -17459.7 | -162.9 | -73.5 | -31.3 | -32.4 | -35.5 | -16.3 | -3.6 |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | -0.2 | 0.0 |
| Net Income | -14411.9 | -159.0 | -46.7 | -23.2 | -34.0 | -33.8 | -14.2 | -1.5 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on XPEV: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.